CNC vs TECH
Centene Corp (CNC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CNC and TECH stock pages for the full models.
Not investment advice.